BANK OF AMERICA CORP /DE/ - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 77 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.36 and the average weighting 1.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$555,397
-30.8%
53,558
-4.5%
0.00%
Q2 2023$803,094
-55.6%
56,082
-77.9%
0.00%
Q1 2023$1,809,883
+146.4%
253,485
+287.2%
0.00%
Q4 2022$734,483
-6.3%
65,462
-7.5%
0.00%
Q3 2022$784,000
+1.6%
70,748
-22.7%
0.00%
Q2 2022$772,000
-15.0%
91,544
+37.3%
0.00%
Q1 2022$908,000
-37.9%
66,660
-10.4%
0.00%
Q4 2021$1,462,000
-29.4%
74,391
+15.3%
0.00%
Q3 2021$2,071,000
-3.8%
64,534
+1.6%
0.00%
Q2 2021$2,152,000
-11.9%
63,544
-2.2%
0.00%
Q1 2021$2,442,000
+83.9%
65,004
+62.6%
0.00%
Q4 2020$1,328,000
+621.7%
39,979
+694.2%
0.00%
Q3 2020$184,000
+22.7%
5,034
+10.5%
0.00%
Q2 2020$150,000
-63.1%
4,555
-71.1%
0.00%
Q1 2020$406,000
+600.0%
15,743
+748.7%
0.00%
Q4 2019$58,0001,8550.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,760,869$39,000,21212.45%
Frazier Life Sciences Management, L.P. 10,109,279$104,833,2236.96%
Decheng Capital Management III (Cayman), LLC 850,000$8,814,5002.94%
Carlyle Group Inc. 3,496,808$36,191,9631.57%
Ghost Tree Capital, LLC 395,000$4,096,1501.35%
Newtyn Management, LLC 500,000$5,185,0001.28%
Altium Capital Management LP 220,000$2,281,4001.19%
StepStone Group LP 422,085$4,377,0210.98%
MPM BioImpact LLC 347,332$3,601,8330.96%
NEA Management Company, LLC 1,276,595$12,238,2900.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders